Answers are grounded in this paper and cite their sources.
. Furthermore, ZZ-MGL could effectively enhance anti-tumor immune responses, by triggering Fc-mediated effector pathways, ultimately translating into significant tumor growth inhibition in a colorectal cancer xenograft mouse model. This chimera platform can potentially be adapted to target other tumor-associated carbohydrate antigens by simply substituting with suitable lectins, highlighting its wide application in cancer immunotherapy.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: